Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
03/12/2008 | EP1897869A1 Novel compound, polymer and radiation-sensitive resin composition |
03/12/2008 | EP1896413A1 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device |
03/12/2008 | EP1896412A2 Oxindole derivatives |
03/12/2008 | EP1896014A2 Chemical compounds |
03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
03/12/2008 | EP1539480A4 Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions |
03/12/2008 | CN101142185A Indoles useful in the treatment of inflammation |
03/12/2008 | CN101142184A Sulfonamide peri-substituted bicyclics for occlusive artery disease |
03/12/2008 | CN101142183A Mitotic kinesin inhibitors |
03/12/2008 | CN101141956A Use of CRTH2 antagonist compounds in therapy |
03/12/2008 | CN101139317A Organic semiconductor material containing carbazole unit and synthesis |
03/12/2008 | CN101139316A Anthraquinone imide compound and method for making same |
03/12/2008 | CN101139315A Method for preparing di(N-methyl phthalimide) ether |
03/12/2008 | CN101139309A Asymmetric star-radiation shaped triphenylamine compound and uses thereof |
03/12/2008 | CN100374459C Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
03/12/2008 | CN100374420C Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
03/12/2008 | CN100374419C Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides |
03/11/2008 | US7342119 Process for the synthesis of a CPLA2 inhibitor |
03/11/2008 | US7342041 viricide; synergistic mixture with antiviral agent (ribavirin) and alpha - or pegylated interferon; Human Immunogeficiency Virus, Acquired Immune Deficiency Syndrome |
03/11/2008 | US7342040 5-fluorooxindole-3-carboxylic acid ester |
03/11/2008 | US7342039 Substituted indole oximes |
03/11/2008 | US7342038 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
03/11/2008 | US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
03/11/2008 | US7342029 Substituted indoles |
03/11/2008 | US7342022 Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3 |
03/11/2008 | US7342014 Diamine derivatives |
03/11/2008 | CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
03/11/2008 | CA2237297C Process for the preparation of (1s,4r)-or(1r,4s)-4-(2-amino-6-chloro-9h-purin-9-yl)-2-cyclopentene-1-methanol |
03/06/2008 | WO2008028118A1 1h-indole-2-carboxylic acid derivatives useful as ppar modulators |
03/06/2008 | WO2008026614A1 Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device |
03/06/2008 | WO2008026563A1 Hydrazine amide derivative |
03/06/2008 | WO2008025361A1 3-(1h-indol-3-yl) indan-1-ylamine derivatives for the treatment of depression and anxiety |
03/06/2008 | WO2008025240A1 Composition comprising amino heterocyclic compound for hair dyeing and dyeing method |
03/06/2008 | WO2007141283A3 Salts and crystalline salt forms of an 2-indolinone derivative |
03/06/2008 | WO2007010356A8 Process for the preparation of sulfonamide derivatives |
03/06/2008 | US20080058535 Methods and compositions for production, formulation and use of 1 aryl-3-azabicyclo[3.1.0]hexanes |
03/06/2008 | US20080058501 Method of Producing a Polymer Network |
03/06/2008 | US20080058497 contacting a crude 2-aryl-3,3-bis(hydroxyaryl)phthalimidine with a purification agent, removing a 2-aryl-3-(aminoaryl)-3-(hydroxyaryl)phthalimidine compound from the crude , and producing a purified 2-aryl-3,3-bis(hydroxyaryl)phthalimidine product |
03/06/2008 | US20080058386 1-(4-Methoxy-benzenesulfonyl)-2,3-dihydro-1H-indol-7-ylamine; inhibiting tubulin polymerization; anticarcinogenic; mitotic arrest of microtubule structure, neovascularization; angiogenesis inhibitor: atherosclerosis, rheumatoid arthritis or Crohn's disease, diabetic retinopathy, psoriasis |
03/06/2008 | US20080058382 Polyamine compounds |
03/06/2008 | US20080058365 Fused heterocyclic compounds |
03/06/2008 | US20080058329 Novel indane compounds |
03/06/2008 | US20080058320 Organic Compounds |
03/06/2008 | US20080056989 Polyhydroxy-polysulphonyl-glucose-benz(e)indoles; absorb and fluoresce in visible region; optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo; tomography; magnetic resonance imaging; benzoindocarbocyanines |
03/06/2008 | CA2662274A1 Chemical compounds |
03/06/2008 | CA2655241A1 3-(1h-indol-3-yl)indan-1-ylamine derivatives for the treatment of depression and anxiety |
03/05/2008 | EP1893588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
03/05/2008 | EP1893583A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists |
03/05/2008 | EP1893576A1 Treatment of protein folding disorders |
03/05/2008 | EP1893575A2 2-(1h-indolylsulfanyl)-aryl amine derivatives |
03/05/2008 | EP1893573A1 Inhibitors of hcv replication |
03/05/2008 | EP1893567A1 Benzanilides with insecticidal activity |
03/05/2008 | EP1893561A1 Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumour agents |
03/05/2008 | EP1893195A2 Polymorphic forms of tegaserod maleate |
03/05/2008 | EP1893194A1 Enhanced indolinone based protein kinase inhibitors |
03/05/2008 | EP1368020B1 Method for identifying maxi-k channel blockers |
03/05/2008 | CN101134757A 稠合杂环化合物 Fused heterocyclic compounds |
03/05/2008 | CN100372855C 7-imino derivatives of camptothecin having antitumor activity |
03/05/2008 | CN100372853C Metal porphyrin nanotube and nanoline and their preparation process |
03/05/2008 | CN100372836C Immunotherapeutic imides/amides |
03/04/2008 | US7339059 Benzofuran-2-yl-carbonyl- and indol-2-yl-carbonyl-trans-2,5-dimethyl-piperazine derivatives; rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, inflammatory bowel disease, asthma; inhibit the interaction between inflammatory chemokines and their receptor |
03/04/2008 | US7338966 Substituted oxindole derivatives as tyrosine kinase inhibitors |
03/04/2008 | US7338805 Labeling reagents, methods for synthesizing such reagents and methods for detecting biological molecules |
02/28/2008 | WO2008024492A2 Indolinone phenylaminopropanol derivatives and process for the preparation thereof |
02/28/2008 | WO2008023720A1 Urea compound or salt thereof |
02/28/2008 | WO2008023336A2 Matrix metalloproteinase inhibitors |
02/28/2008 | WO2007138282A3 Bi-aryl or aryl-heteroaryl substituted indoles |
02/28/2008 | WO2007022459A3 Processes and intermediates |
02/28/2008 | WO2007016136A3 Organic nitric oxide enhancing salts of cyclooxygenase-2 selective inhibitors, compositons and methods of use |
02/28/2008 | US20080051586 [4-Acetylamino-3-(4-chlorophenylsulfanyl)-2-methyl-1H-indol-1-yl]acetic acid; cleavage of dichloroDIPHENYL DISULFIDE to form the p-chloro thioether; reduction of nitro group; respiratory diseases |
02/28/2008 | US20080051585 Process for the preparation of indolin-2-one derivatives useful as PR modulators |
02/28/2008 | US20080051584 Process For The Preparation Of Perindopril And Salts Thereof |
02/28/2008 | US20080051327 Crystals of an Aurora-A Tpx2 Complex, Tpx2 Binding Site of Aurora-A, Aurora-A Ligands and Their Use |
02/28/2008 | US20080051321 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
02/28/2008 | US20080048155 Filter and Cyanine Compound |
02/28/2008 | CA2665804A1 Urea compound or salt thereof |
02/28/2008 | CA2661299A1 Matrix metalloproteinase inhibitors |
02/27/2008 | EP1892240A1 Benzoisoindole derivative, pigment composition comprising the same and colored composition |
02/27/2008 | EP1892239A1 Inhibitors of cytosolic phospholipase A2 |
02/27/2008 | EP1891971A1 Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
02/27/2008 | EP1891951A1 Viral polymerase inhibitors |
02/27/2008 | EP1891950A1 Viral polymerase inhibitors |
02/27/2008 | EP1891073A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
02/27/2008 | EP1891008A1 Oxindoles as kinase inhibitors |
02/27/2008 | EP1891007A1 Indole derivatives having antitumor activity |
02/27/2008 | EP1891006A2 Inhibitors of cytosolic phospholipase a2 |
02/27/2008 | EP1890703A2 Pyrimidine compounds |
02/27/2008 | EP1615904B1 Substituted benzosulphonamides as potentiators of glutamate receptors |
02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
02/27/2008 | CN101133060A Enzyme inhibitors |
02/27/2008 | CN101133024A Amide derivatives as inhibitors of histone deacetylase |
02/27/2008 | CN101133010A Process and intermediate compounds useful in the preparation of statins |
02/27/2008 | CN101130517A Technique for refining carbazole |
02/27/2008 | CN101130516A Method for purifying and enriching benzene acryloyl 5- hydroxytryptamine derivant in safflower seed |
02/27/2008 | CN101130515A Substituted-1H- indoles compound, method for preparing the same, application and pharmaceutical composition of the same |
02/27/2008 | CN100371325C Indenoindole ketone kind compound, its preparation method and use |
02/27/2008 | CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
02/26/2008 | US7335961 Magnetic random access memory array with coupled soft adjacent magnetic layer |
02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |